(S)-5-methoxy-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 98%, 1g

2H-Imidazo[4,5-c]quinolin-2-one, 7-(3,5-dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-, 98%, 5mg

6-Bromo-benzothiazol-2-ylamine, 98.0%, 100g

Antimony(III) Chloride500g

4-Nitrophenyl b-D-xylopyranoside, 95.0%, 250mg

4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonic acid, 95.0%, 250mg

Methyl 4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 25g

4-Chloro-3,5-difluoro-DL-phenylalanine, 1g

6-Chloro-2-fluoro-3-methoxybenzyl alcohol, 10g

1-(5-BROMOPYRIDIN-2-YL)ETHANAMINE HCL, 95.0%, 100mg

GC capillary column ROTI®Cap-1, 10 m, 0.25 mm, 0.25 µm, 1 Piece(s)

5-[(tert-Butoxycarbonyl)amino]-2-chloroisonicotinic acid, 97.0%, 5g

2-Amino-3,3,3-trifluoropropan-1-ol hydrochloride, 95.0%, 250mg